title: Society of cardiovascular anesthesiologists: the effect of blood pressure regulation during aortic coarctation repair on brain, kidney, and muscle oxygen saturation measured by near-infrared spectroscopy: a randomized, clinical trial.
abstract: BACKGROUND
  In this study, we compared the effects of 3 frequently used arterial blood pressure-regulating agents on brain (rScO2), renal (SrO2), and muscle (SmO2) oxygen saturation, during aortic coarctation repair in children. Based on the reported adverse effect of sodium nitroprusside (SNP) on left-sided rScO2 during aortic coarctation repair, we tested the hypothesis that the alterations in left rScO2 occurring with SNP would not be present with sevoflurane and nitroglycerin (NTG). Additionally, we explored the effects of blood pressure regulation with SNP, NTG, or sevoflurane on right-sided rScO2, SrO2, and SmO2.
  
  
  METHODS
  Children with isolated aortic coarctation undergoing surgical repair through a left thoracotomy without the use of cardiopulmonary bypass were considered eligible for the study. During aortic cross-clamping, control of mean arterial blood pressure (MAP) was conducted according to randomization by the use of SNP, NTG, or sevoflurane to obtain a mean target right brachial blood pressure of 120% to 150% of the MAP value before cross-clamping. Bilateral rScO2, SrO2, and SmO2 were recorded continuously with near-infrared spectroscopy. As a primary end point, the maximal relative change in left-sided rScO2 in response to aortic cross-clamping was compared among treatment groups.
  
  
  RESULTS
  Ten patients per group were included. No significant difference among treatment groups was observed in maximal relative change in left-sided rScO2 (SNP versus sevoflurane: mean difference -0.7%, 99% confidence interval [CI] -31% to 29%, P = 1.0; SNP versus NTG: mean difference -1.8%, 99% CI -32% to 28%, P = 1.0; sevoflurane versus NTG: mean difference -1.1%, 99% CI -31% to 29%, P = 1.0). Additional analyses also detected no difference between groups in right rScO2 (P = 0.4). Compared with NTG, treatment with SNP resulted in a significantly larger (-64% ± 17% vs -34% ± 25%, P = 0.01) and faster (-9 ± 4 %·min(-1) vs -4 ± 3 %·min(-1), P = 0.004) decrease in SmO2. Right-sided rScO2 and MAP showed a poor correlation for NTG (r = -0.2, P = 0.93), whereas borderline for sevoflurane (r = 0.44, P = 0.09) and SNP (r = 0.56, P = 0.04).
  
  
  CONCLUSIONS
  The mean differences in left-sided rScO2 among the patients treated with SNP, NTG, or sevoflurane for proximal hypertension during aortic cross-clamping were no more than 32%. Additional analysis demonstrated a low MAP-rScO2 dependence with the use of NTG. Because NTG also resulted in a smaller and slower decrease of oxygen saturation in peripheral tissues, our data suggest that its use might be preferable for proximal blood pressure control during surgical procedures involving aortic cross-clamping.
authors: Department of Anesthesiology, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium. annelies.moerman@UGent.b
authors: Annelies
authors: A
authors: Moerman
authors: Thierry
authors: T
authors: Bové
authors: Katrien
authors: K
authors: François
authors: Stefan
authors: S
authors: Jacobs
authors: Isabel
authors: I
authors: Deblaere
authors: Patrick
authors: P
authors: Wouters
authors: Stefan
authors: S
authors: De Hert
mesh_terms: D000375:Aging / Q000502:physiology; D000771:Anesthesia, Intravenous; D001017:Aortic Coarctation / Q000601:surgery*; D001794:Blood Pressure / Q000502:physiology*; D001923:Brain Chemistry / Q000187:drug effects*; D006348:Cardiac Surgical Procedures / Q000379:methods*; D003250:Constriction; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007432:Intraoperative Period; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D016343:Monitoring, Intraoperative; D018482:Muscle, Skeletal / Q000187:drug effects / Q000378:metabolism*; D005996:Nitroglycerin / Q000494:pharmacology; D009599:Nitroprusside / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects / Q000502:physiology*; D011446:Prospective Studies; D019265:Spectroscopy, Near-Infrared; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D014665:Vasodilator Agents; D009599:Nitroprusside; D005996:Nitroglycerin